Literature DB >> 5050371

Antitumor alkaloids for Cephalataxus harringtonia: structure and activity.

R G Powell, D Weisleder, C R Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5050371     DOI： 10.1002/jps.2600610812

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  35 in total

Review 1.  Potential of plant-derived natural products in the treatment of leukemia and lymphoma.

Authors:  David M Lucas; Patrick C Still; Lynette Bueno Pérez; Michael R Grever; A Douglas Kinghorn
Journal:  Curr Drug Targets       Date:  2010-07       Impact factor: 3.465

2.  Crown Gall Tumor Disc Bioassay: A POSSIBLE AID IN THE DETECTION OF COMPOUNDS WITH ANTITUMOR ACTIVITY.

Authors:  A G Galsky; J P Wilsey
Journal:  Plant Physiol       Date:  1980-02       Impact factor: 8.340

3.  Inhibition of protein synthesis in intact HeLa cells.

Authors:  J S Tscherne; S Pestka
Journal:  Antimicrob Agents Chemother       Date:  1975-10       Impact factor: 5.191

4.  Establishment of fast-growing callus and root cultures of Cephalotaxus harringtonia.

Authors:  E R Wickremesinhe; R N Arteca
Journal:  Plant Cell Rep       Date:  1993-01       Impact factor: 4.570

Review 5.  Plant-derived natural product research aimed at new drug discovery.

Authors:  Hideji Itokawa; Susan L Morris-Natschke; Toshiyuki Akiyama; Kuo-Hsiung Lee
Journal:  J Nat Med       Date:  2008-04-22       Impact factor: 2.343

Review 6.  The role of plant-derived drugs and herbal medicines in healthcare.

Authors:  P A De Smet
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

7.  Cytotoxicity and cell cycle specificity of homoharringtonine.

Authors:  D M Baaske; P Heinstein
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

8.  Omacetaxine: a protein translation inhibitor for treatment of chronic myelogenous leukemia.

Authors:  Varsha Gandhi; William Plunkett; Jorge E Cortes
Journal:  Clin Cancer Res       Date:  2014-02-05       Impact factor: 12.531

9.  Homoharringtonine: a phase I evaluation.

Authors:  J A Stewart; I H Krakoff
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

10.  Comparative in vitro antitumor activity of homoharringtonine and harringtonine against clonogenic human tumor cells.

Authors:  T L Jiang; R H Liu; S E Salmon
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.